Skip to search.
 TSX Up 0.27% TSX Ventures Up 0.84%

Baxter International Inc. (BAX)

-NYSE
43.09 Down 0.22(0.51%) 12:09PM EDT - Nasdaq Real Time Price
Prev Close:43.31
Open:43.31
Bid:43.14 x 700
Ask:43.15 x 900
1y Target Est:48.82
Beta:0.736266
Earnings Date:Jul 27 - Aug 1 (Est.)
Day's Range:42.92 - 43.43
52wk Range:32.18 - 46.95
Volume:2,332,809
Avg Vol (3m):10,005,300
Market Cap:23.80B
P/E (ttm):6.05
EPS (ttm):7.13
Div & Yield:0.52 (1.20%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BAXDown 0.51%23.80B
BDXDown 0.83%35.14B

Key Statistics

Forward P/E (1 yr):22.70
P/S (ttm):2.41
Ex-Dividend Date:02-Mar-16

Analysts

Annual EPS Est (Dec-16) :1.64
Quarterly EPS Est (Jun-16) :0.39
Mean Recommendation*:2.9
PEG Ratio (5 yr expected):2.28

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Baxter International Inc. provides a portfolio of renal and hospital products. Its Renal segment provides products and services to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback